1. 5-fluorouracil pharmacogenomics: still rocking after all these years?. (February 2011) Authors: Scartozzi, Mario; Maccaroni, Elena; Giampieri, Riccardo; Pistelli, Mirco; Bittoni, Alessandro; Del Prete, Michela; Berardi, Rossana; Cascinu, Stefano Journal: Pharmacogenomics Issue: Volume 12:Number 2(2011) Page Start: 251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 5-fluorouracil pharmacogenomics: still rocking after all these years?. (February 2011) Authors: Scartozzi, Mario; Maccaroni, Elena; Giampieri, Riccardo; Pistelli, Mirco; Bittoni, Alessandro; Del Prete, Michela; Berardi, Rossana; Cascinu, Stefano Journal: Pharmacogenomics Issue: Volume 12:Number 2(2011) Page Start: 251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Mixed-apprOach program To help women wIth breast cancer stay actiVE (MOTIVE program): A pilot-controlled study. Issue 11 (November 2021) Authors: Natalucci, Valentina; Lucertini, Francesco; Vallorani, Luciana; Brandi, Giorgio; Marchegiani, Manuela; Pistelli, Mirco; Berardi, Rossana; Ceravolo, Maria Gabriella; Barbieri, Elena; Capecci, Marianna Journal: Heliyon Issue: Volume 7:Issue 11(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Mixed-apprOach program To help women wIth breast cancer stay actiVE (MOTIVE program): A pilot-controlled study. Issue 11 (November 2021) Authors: Natalucci, Valentina; Lucertini, Francesco; Vallorani, Luciana; Brandi, Giorgio; Marchegiani, Manuela; Pistelli, Mirco; Berardi, Rossana; Ceravolo, Maria Gabriella; Barbieri, Elena; Capecci, Marianna Journal: Heliyon Issue: Volume 7:Issue 11(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A Mixed-apprOach program To help women wIth breast cancer stay actiVE (MOTIVE program): A pilot-controlled study. Issue 11 (November 2021) Authors: Natalucci, Valentina; Lucertini, Francesco; Vallorani, Luciana; Brandi, Giorgio; Marchegiani, Manuela; Pistelli, Mirco; Berardi, Rossana; Ceravolo, Maria Gabriella; Barbieri, Elena; Capecci, Marianna Journal: Heliyon Issue: Volume 7:Issue 11(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti‐HER2 agents in the real world setting. Issue 7 (7th August 2019) Authors: Pizzuti, Laura; Krasniqi, Eriseld; Barchiesi, Giacomo; Della Giulia, Marina; Izzo, Fiorentino; Sanguineti, Giuseppe; Marchetti, Paolo; Mazzotta, Marco; Giusti, Raffaele; Botticelli, Andrea; Gamucci, Teresa; Natoli, Clara; Grassadonia, Antonino; Tinari, Nicola; Iezzi, Laura; Tomao, Silverio; Tomao... Journal: International journal of cancer Issue: Volume 146:Issue 7(2020) Page Start: 1917 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Eribulin in Male Patients With Breast Cancer: The First Report of Clinical Outcomes. (14th October 2016) Authors: Giotta, Francesco; Acito, Luigi; Candeloro, Giampiero; Del Medico, Pietro; Gadaleta-Caldarola, Gennaro; Giordano, Guido; Gueli, Rossana; Lugini, Antonio; Magri, Valentina; Mandarà, Marta; Masci, Giovanna; Pisconti, Salvatore; Pistelli, Mirco; Rizzi, Anna; Salesi, Nello; Schirone, Alessio; Scognam... Journal: Oncologist Issue: Volume 21:Number 11(2016) Page Start: 1298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Eribulin in Male Patients With Breast Cancer: The First Report of Clinical Outcomes. (14th October 2016) Authors: Giotta, Francesco; Acito, Luigi; Candeloro, Giampiero; Del Medico, Pietro; Gadaleta‐Caldarola, Gennaro; Giordano, Guido; Gueli, Rossana; Lugini, Antonio; Magri, Valentina; Mandarà, Marta; Masci, Giovanna; Pisconti, Salvatore; Pistelli, Mirco; Rizzi, Anna; Salesi, Nello; Schirone, Alessio; Scognam... Journal: Oncologist Issue: Volume 21:Number 11(2016) Page Start: 1298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Healthcare cost of HER2-positive and negative breast tumors in the United States (2012–2035). (November 2017) Authors: Tartari, Francesca; Santoni, Matteo; Pistelli, Mirco; Berardi, Rossana Journal: Cancer treatment reviews Issue: Volume 60(2017) Page Start: 12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real‐world evidence. Issue 11 (15th January 2020) Authors: Krasniqi, Eriseld; Pizzuti, Laura; Barchiesi, Giacomo; Sergi, Domenico; Carpano, Silvia; Botti, Claudio; Kayal, Ramy; Sanguineti, Giuseppe; Marchetti, Paolo; Botticelli, Andrea; Marinelli, Daniele; Gamucci, Teresa; Natoli, Clara; Grassadonia, Antonino; Tinari, Nicola; Tomao, Silverio; Tonini, Giu... Journal: Journal of cellular physiology Issue: Volume 235:Issue 11(2020:Nov.) Page Start: 7900 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗